MiraVista Diagnostics

MiraVista Diagnostics is a CAP- and CLIA-certified clinical reference laboratory specializing exclusively in diagnostic testing for serious fungal infections. Founded in 2002 by renowned infectious disease scientist Lawrence Joseph Wheat, MD, the company has established itself as the leading authority in mycological diagnostics. MiraVista processes over 100,000 diagnostic tests annually for blastomycosis, histoplasmosis, cryptococcosis, aspergillosis, coccidioidomycosis, and beta-D glucan detection across multiple specimen types including bronchoalveolar lavage (BAL) fluid. The laboratory offers both antigen-detection methods (EIA, latex agglutination) and molecular diagnostic assays, including the newly available MVista® Fungal PCR Panel for pulmonary fungal pathogen multiplex detection. The company provides same-day testing with prompt turnaround times and employs experienced infectious disease specialists. With over 1,000 peer-reviewed publications in leading infectious disease and clinical laboratory journals, MiraVista serves hospital laboratories, clinicians, and researchers requiring high-complexity fungal serology and molecular diagnostics. The organization also operates a parallel veterinary diagnostic division (MiraVistaVets.com). Regulatory compliance includes CAP and CLIA certifications, positioning the laboratory for clinical and reference testing across academic medical centers, community hospitals, and specialized infection control programs.